INTRODUCTION
============

Endoscopic submucosal dissection (ESD) has become a useful method for the treatment of selected cases of gastric neoplasms, enabling *en bloc* resection \[[@B1]-[@B5]\]. ESD is an effective and minimally invasive procedure, and it can preserve more of the stomach than surgical resection. However, the remnant stomach after such treatment is at high risk for the development of multiple gastric lesions, defined as neoplasms that develop subsequently at another site in the stomach \[[@B6]-[@B8]\]. In fact, the reported incidence of cancer in the gastric remnant is 1.8% to 5% in patients who have undergone surgical treatment for gastric cancer \[[@B9],[@B10]\], while the reported incidence of multiple gastric cancers is 9% to 24% in patients who have undergone endoscopic resection of a gastric cancer \[[@B6],[@B11]-[@B13]\].

Despite numerous reports on the characteristics of synchronous and metachronous lesions after endoscopic treatment \[[@B6],[@B7],[@B11]-[@B14]\], appropriate surveillance strategies after gastric endoscopic treatment remain unclear. Here, we describe the incidence of and factors associated with synchronous and metachronous gastric lesions in patients with early gastric cancer (EGC) or adenoma after ESD.

METHODS
=======

Patients
--------

From January 2008 to December 2011, 630 patients with EGC or adenoma were treated with ESD at Presbyterian Medical Center (Jeonju, Korea). Of the 630 patients, we excluded 118 who were followed for \< 1 month; thus, 512 patients who underwent ESD for EGC or adenoma were reviewed retrospectively ([Fig. 1](#F1){ref-type="fig"}). Each ESD had been undertaken with curative intent and informed written consent was obtained from all patients before the procedure. Initial and periodic endoscopic examinations were performed at Presbyterian Medical Center. Follow-up esophagogastroduodenoscopy (EGD) was started within 3 months after the initial ESD; surveillance EGD was performed every 6 to 12 months thereafter.

Clinicopathological evaluations
-------------------------------

Clinical characteristics, histopathology, and tumor recurrence were analyzed. All endoscopic findings were reviewed for data related to the size, location, and gross findings of the tumor. We compared the clinicopathological factors between two patient groups: solitary versus multiple lesions. For patients with multiple lesions, only the main lesions were compared. In cases with missed synchronous and metachronous lesions, the initial ESD lesion was considered the main lesion. For patients with initial synchronous lesions, the most malignant or dysplastic lesion was considered the main lesion. In the case of initially detected multiple lesions with the same histology, the largest lesion was considered the main lesion. Tumor location (long axis) was classified by dividing the stomach into three equal sections: upper (cardia, fundus, and upper body), middle (midbody, lower body, and angle), and lower (antrum and prepylorus). The maximum tumor diameter in the gastric lesion was measured as the tumor size. The gastric lesions were divided into two gross types: elevated and depressed lesions. Information regarding the status of the background gastric mucosa and intestinal metaplasia was evaluated histologically in 435 patients. We analyzed the incidence of synchronous and metachronous lesions and yearly incidence rates of metachronous lesions after ESD. Furthermore, we compared the clinicopathological factors between primary and secondary lesions in patients with multiple lesions.

Definitions
-----------

We defined lesions that developed subsequently at another site in the stomach after ESD as multiple gastric neoplasms, according to Moertel\'s criteria \[[@B15]\]. We considered gastric neoplasms detected within 1 year after ESD as synchronous lesions. These consisted of initially detected multiple neoplasms and missed synchronous lesions, defined as secondary gastric neoplasms detected within 1 year of ESD but missed endoscopically at the time of ESD \[[@B14]\]. Metachronous lesions were defined as secondary gastric neoplasms occurring at least 1 year after the initial ESD \[[@B6]-[@B8],[@B11],[@B12]\].

Statistical analyses
--------------------

We performed chi-square and Mann-Whitney *U* tests to compare the clinicopathological factors between the groups. Factors affecting multiple gastric neoplasms were identified using a multivariate logistic regression with SPSS software version 19 (IBM Co., Armonk, NY, USA); *p* \< 0.05 was considered to indicate statistical significance.

RESULTS
=======

Of 630 EGC or adenoma patients who were initially treated with ESD, 512 were followed by endoscopy and were included in the analysis. The characteristics of these 512 patients are listed in [Table 1](#T1){ref-type="table"}. The median age at diagnosis was 66 years (range, 23 to 90), and the mean follow-up period by endoscopy was 16 months (range, 1 to 52). No patient died of a gastric neoplasm, and there were no treatment-related deaths.

In total, 66 patients (12.9%) developed synchronous gastric neoplasms, of which 53 had initially detected synchronous lesions and 19 had missed synchronous lesions; six patients had both initial synchronous and missed synchronous lesions. A total of 13 patients (2.5%) developed metachronous gastric neoplasms and 74 (14.5%) had synchronous and/or metachronous multiple gastric lesions ([Fig. 1](#F1){ref-type="fig"}). Five patients had both synchronous and metachronous lesions. Ten patients had more than three gastric neoplasms; one of them had multiple gastric neoplasms initially, and nine patients subsequently had third or fourth gastric neoplasms. The median interval between the primary ESD and diagnosis of the first metachronous neoplasm was 31 months (range, 15 to 45). One patient with metachronous EGC underwent surgery because of a combined cholangiocarcinoma. The remaining 12 patients were successfully treated with endoscopic resection. The mean annual incidence rate of metachronous lesions was approximately 3% ([Fig. 2](#F2){ref-type="fig"}).

In a univariate analysis, multiple lesions occurred more frequently in patients of advanced age (\> 65 years), and in the middle-third location (*p* = 0.016 and *p* = 0.033, respectively). Histopathological evaluations were performed on 435 patients (solitary group, n = 368; multiple group, n = 67) during the 12 months before and after ESD. The presence of intestinal metaplasia in the surrounding mucosa correlated significantly with multiple lesions (*p* = 0.047) ([Table 1](#T1){ref-type="table"}).

In a multivariate analysis of the occurrence of the multiple lesions, only old age (\> 65 years) showed a significant correlation (odds ratio, 2.05; 95% confidence interval, 1.1 to 3.5; *p* = 0.012). Intestinal metaplasia and sex showed no association with multiple lesions ([Table 2](#T2){ref-type="table"}).

The clinicopathological characteristics of the 74 patients who had multiple gastric lesions are shown in [Table 3](#T3){ref-type="table"}. Half of these lesions were located in the same third of the stomach as the primary lesions, and two-thirds of these lesions showed similarities in macroscopic and histological type with the primary lesions.

DISCUSSION
==========

Endoscopic resection is now widely accepted as a standard treatment for selected cases of gastric neoplasms \[[@B2]-[@B4],[@B8]\]. While endoscopic resection can preserve the stomach and help maintain the postoperative quality of life for patients, endoscopic resection increases the risk of synchronous or metachronous multiple lesions in the remnant gastric mucosa \[[@B6]-[@B8],[@B11]-[@B13]\]. Thus, establishing an optimal surveillance strategy is important for detecting multiple lesions during the early stages of disease and avoiding surgery for secondary lesions \[[@B7],[@B8]\].

There are several reports on the predictive factors for multiple lesions after endoscopic resection. Arima et al. \[[@B6]\] reported that metachronous recurrence was more frequent in patients with synchronous multiplicity, while Han et al. \[[@B11]\] reported that old age and antrum atrophy were associated with metachronous cancer. Seo et al. \[[@B13]\] also noted that an undifferentiated histology of the EGC may predict multiple lesions. In this study, only patients of advanced age (\> 65 years) showed an increased risk of multiple gastric neoplasms. Several studies have shown a significant effect of *Helicobacter pylori* eradication on reducing the incidence of metachronous cancer after endoscopic resection for EGC \[[@B16],[@B17]\]. Additionally, it was reported that patients with microsatellite instability-positive and intestinal claudin-positive cancers had a significantly higher risk of both synchronous and metachronous multiple cancers after endoscopic resection \[[@B18]-[@B21]\].

Previous studies have shown that the mean annual incidence rate of metachronous lesions after endoscopic resection was 3% to 4%, while the median interval between primary endoscopic resection and the diagnosis of a metachronous lesion was 30 to 37 months \[[@B7],[@B8],[@B11],[@B12]\]. Consistent with these data, in our study, the mean annual incidence rate of metachronous lesions was 3%, and the median interval of occurrence of metachronous lesions was 31 months.

To date, the optimal surveillance schedule for detecting multiple lesions remains unclear. In this study, follow-up EGD was started within 3 months after the initial ESD, and surveillance EGD was performed every 6 to 12 months. Those patients with metachronous lesions, except one patient with EGC and cholangiocarcinoma, were treated successfully with endoscopic resection. In one clinical study of metachronous gastric neoplasms, the cumulative incidence curve of metachronous occurrence generally increased steadily to 6.5 years and was generally flat to 10 years \[[@B7]\].

There are four reports on metachronous cancer evaluated with more than 10 years of follow-up after endoscopic resection; in those reports, no metachronous cancer was detected after a 10-year interval \[[@B7],[@B12],[@B22],[@B23]\]. In particular, Kobayashi et al. \[[@B23]\] reported that the high risk of metachronous cancers did not continue after 10 years. Based on these studies, we suggest that annual surveillance is needed for at least 5 years and probably until 10 years after the initial ESD.

In a study by Nasu et al. \[[@B12]\], half of the multiple lesions were located in the same third of the stomach, and most multiple lesions were similar in macroscopic and histological type to the primary lesions. We found similar results in this study. Therefore, similarities in multiple lesions may aid the detection of secondary lesions during follow-up endoscopy.

Our study has several limitations. First, the mean observation period was relatively short at 16 months. Second, this study had insufficient exclusion criteria; patients with additional gastrectomies, incomplete resection (piecemeal, margin-positive, or unclear), and follow-up periods of \< 1 year were included in our population. Third, our data on the presence of intestinal metaplasia were incomplete because they were collected retrospectively from medical records.

In conclusion, we recommend more careful follow-up in patients of advanced age (\> 65 years) after gastric ESD, and endoscopists should make note of similarities among multiple lesions. Annual surveillance might help in detecting metachronous lesions after an initial ESD. Large-scale, multicenter, and longer prospective studies are needed to determine the most appropriate surveillance strategy.

KEY MESSAGE
===========

1\. Older (\> 65 years) patients with early gastric cancer or gastric adenoma who had undergone endoscopic submucosal dissection had an increased risk of multiple gastric neoplasms.

2\. About two-thirds of the multiple lesions were similar in macroscopic and histological type to the primary lesions.

3\. Annual surveillance might aid in the detection of metachronous lesions.
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###### 

Baseline characteristics of those patients with gastric neoplasms and their initially resected lesions
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Values are presented as number (%) or median (range).

^a^Determined by the Mann-Whitney *U* test.

^b^Histopathological evaluations were performed in 435 patients (solitary, n = 368; multiple, n = 67) during the 12 months before and after endoscopic submucosal dissection.

###### 

Predictive factors associated with multiple lesions based on a multivariate logistic regression analysis
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CI, confidence interval.

###### 

Clinicopathological similarities in multiple lesions
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Values are presented as number (%).

U/M/L, upper/middle/lower; E/D, elevated/depressed; A/Di/Un, adenoma/differentiated adenocarcinoma/undifferentiated adenocarcinoma.

^a^Five patients had both synchronous and metachronous cancers. They are grouped with the metachronous lesion subgroup.
